Research article Open access
Short-term efficacy and safety of intravitreal brolucizumab in diabetic macular edema: A retrospective interventional study
Objectives: This study aims to evaluate the efficacy and safety of intravitreal brolucizumab (IVBr), a novel antivascular endothelial growth factor agent, in the treatment of diabetic macular edema (DME) by assessing both functional (visual) and structural (anatomical) improvements. Materials and methods: A retrospecti …